Respiration,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 13
Published: Aug. 13, 2024
Introduction:
Endobronchial
ultrasound-guided
transbronchial
needle
aspiration
(EBUS-TBNA)
can
be
limited
by
the
inadequacy
of
intact
tissues,
especially
in
patients
with
lymphoma,
sarcoidosis,
and
lymph
node
tuberculosis.
A
novel
technique
called
biopsy
(TBNB)
forceps
or
cryoprobe
has
been
proposed
studied
to
improve
specimen
quality
diagnostic
yield.
We
performed
a
systematic
review
studies
describing
safety
sensitivity
EBUS-TBNB
versus
EBUS-TBNA
diagnosing
intrathoracic
lymphadenopathy/masses.
Methods:
systematically
searched
MEDLINE,
Embase,
Cochrane,
China
National
Knowledge
Infrastructure
identify
focusing
on
application
for
diagnosis
lymphadenopathy.
The
each
study
was
evaluated
using
QUADAS-2
tool.
Using
inverse-variance
(I-V)
weighting,
we
meta-analysis
yield
estimations.
also
reviewed
complications
related
procedure.
Results:
Thirteen
were
included
final
analysis.
yielded
pooled
overall
77.80%
(939/1,207)
86.01%
(834/958)
EBUS-TBNB,
an
inverse-variance-weighted
odds
ratio
3.13
(95%
confidence
interval
[CI],
1.61–6.01;
p
=
0.0008)
I2
82%.
malignancy
(including
primary
lung
cancer
extrapulmonary
malignancy)
84.53%
(590/698)
90.84%
(476/524)
I-V-weighted
OR
2.33
CI,
1.15–4.74;
0.02)
64%.
benignancy
71.19%
(252/354)
86.62%
(233/269)
4.39
2.00–9.65;
0.002)
59%.
bleeding
(n
11,
0.90%),
pneumomediastinum
6,
0.49%),
pneumothorax
pneumonia
4,
0.33%),
respiratory
failure
1,
0.08%),
haemoptysis
0.08%).
funnel
plot
analysis
illustrated
no
major
publication
bias.
Conclusions:
improves
sampling
lymphadenopathy
mass
lesions
relative
EBUS-TBNA.
complication
rate
is
higher
than
that
but
reportedly
lower
surgical
biopsies.
Pulmonology,
Journal Year:
2024,
Volume and Issue:
30(5), P. 459 - 465
Published: Jan. 5, 2024
Endobronchial
Ultrasound
(EBUS)
has
emerged
as
a
crucial
tool
for
diagnosing
intrathoracic
disorders,
particularly
in
the
staging
of
lung
cancer.
However,
its
diagnostic
capabilities
context
benign
and
rare
diseases
remain
subject
debate.
to
investigate
yield
safety
EBUS-transbronchial
mediastinal
cryobiopsy
(EBUS-TMC)
comparison
needle
aspiration
(TBNA)
broad
spectrum
diseases.
single-centre
retrospective
observational
study
conducted
on
48
patients
who
underwent
both
EBUS-TBNA
endobronchial
ultrasound-transbronchial
same
procedure
between
August
2021
October
2023.
The
overall
EBUS-TMC
surpassed
that
(95.8%
vs
54.1
%),
notably
excelling
diagnosis
sarcoidosis
(92.8%
78.5
disorders
(100%
0
hyperplastic
lymphadenopathy
lymphoproliferative
disease
%).
No
significant
differences
were
observed
NSCLC
SCLC.
Samples
obtained
through
facilitated
acquisition
NGS
immunohistochemical
analyses
more
readily.
may
contribute
precise
subtyping
diseases,
especially
lymphomas
tumors,
thereby
reducing
number
non-diagnostic
procedures.
Pulmonology,
Journal Year:
2024,
Volume and Issue:
30(5), P. 466 - 474
Published: Jan. 5, 2024
Endobronchial
ultrasound-guided
transbronchial
needle
aspiration
(EBUS-TBNA)
is
the
standard
approach
for
lung
cancer
staging.
However,
its
diagnostic
utility
other
mediastinal
diseases
might
be
hampered
by
limited
tissue
retrieved.
Recent
evidence
suggests
novel
sampling
strategies
of
forceps
biopsy
and
cryobiopsy
as
auxiliary
techniques
to
EBUS-TBNA,
considering
their
capacity
larger
samples.
This
study
determined
added
value
diagnosis
diseases.
Consecutive
patients
with
lesions
1
cm
or
more
in
short
axis
were
enrolled.
Following
completion
aspiration,
three
biopsies
one
performed
a
randomised
pattern.
Primary
endpoints
included
yield
defined
percentage
whom
led
definite
diagnosis,
procedure-related
complications.
In
total,
155
recruited
randomly
assigned.
Supplementing
EBUS-TBNA
either
increased
yield,
no
significant
difference
between
plus
(85.7
%
versus
91.6
%,
P
=
0.106).
Yet,
samples
obtained
additional
cryobiopsies
qualified
molecular
testing
than
those
from
(100.0
89.5
0.036).
When
compared
directly,
overall
was
superior
70.8
0.001).
Cryobiopsies
produced
greater
shorter
procedural
time
biopsies.
Two
(1.3
%)
cases
postprocedural
pneumothorax
detected.
Transbronchial
promising
complementary
tool
supplement
traditional
harvesting.
ChiCTR2000030373
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Aug. 21, 2023
Despite
remarkable
advances
in
tumor
response
and
patient
survival
the
past
decade,
systemic
immunotherapies
for
lung
cancer
result
an
objective
only
around
half
of
patients
treated.
On
basis
this
limitation,
combination
strategies
are
being
investigated
to
improve
rates.
Cryoablation
has
been
proposed
as
one
such
technique
induce
immunogenic
cell
death
synergize
with
immunotherapies,
including
immune
checkpoint
inhibitors.
traditionally
delivered
percutaneously
imaging
guidance
although
recent
technological
allow
bronchoscopic
delivery.
Herein,
we
review
pre-clinical
clinical
evidence
use
cryoablation
non-small
potential
induction
anti-tumor
immunity.
We
highlight
ongoing
studies
involving
approach
propose
areas
future
investigation.
Respiration,
Journal Year:
2024,
Volume and Issue:
103(7), P. 359 - 367
Published: Jan. 1, 2024
Endobronchial
ultrasound-guided
transbronchial
mediastinal
cryobiopsy
(EBUS-TMC),
a
novel
technique,
has
been
reported
to
improve
the
diagnostic
value
of
endobronchial
needle
aspiration
(EBUS-TBNA)
for
lesions
in
recent
studies.
Current
literature
suggests
that
this
procedure
greater
efficacy
compared
conventional
EBUS-TBNA.
This
systematic
review
and
meta-analysis
aimed
evaluate
yield
complications
associated
with
EBUS-TMC
comparison
EBUS-TBNA,
thereby
exploring
potential
technique
enhancing
utility
lesions.
Mediastinum,
Journal Year:
2024,
Volume and Issue:
8, P. 2 - 2
Published: Jan. 10, 2024
Background
and
Objective:
Endobronchial
ultrasound-guided
transbronchial
needle
aspiration
(EBUS-TBNA)
is
a
minimally
invasive,
safe,
well-established
method
for
diagnosing
staging
lung
cancer
other
conditions
associated
with
mediastinal
lymphadenopathy.
Efforts
have
been
made
to
enhance
the
material
adequacy
of
EBUS-TBNA,
including
recent
introduction
EBUS-guided
cryobiopsy
(EBUS-TMC).
This
advancement
facilitates
acquisition
larger
better-preserved
tissue
samples
from
mediastinum.
We
evaluated
diagnostic
accuracy
safety
EBUS-TMC
in
diagnosis
malignant
lesions
its
effectiveness
relation
benign
conditions,
such
as
tuberculosis
sarcoidosis.
Methods:
searched
PubMed®
database
relevant
English
articles
published
up
July
1,
2023.
Subsequently,
we
conducted
comprehensive
bibliographic
analysis
particular
emphasis
on
yield,
profile,
procedural
technicalities.
Key
Content
Findings:
Our
narrative
review,
comprising
seven
publications,
emphasizes
significance
an
effective
technique
obtaining
while
maintaining
excellent
profile.
Furthermore,
capability
molecular
immunological
non-small
cell
cancer.
Conclusions:
exhibits
significant
efficacy
regard
conditions.
However,
further
studies
are
needed
evaluate
uncertainties
regarding
selection
suitable
cases
technical
intricacies.
Lung India,
Journal Year:
2024,
Volume and Issue:
41(4), P. 288 - 298
Published: June 28, 2024
ABSTRACT
Background:
Modalities
to
improve
tissue
acquisition
during
endobronchial
ultrasound-guided
transbronchial
needle
aspiration
(EBUS-TBNA)
have
been
investigated.
Endobronchial
mediastinal
cryobiopsy
(EBUS-TMC)
is
a
modality
obtain
larger
histological
samples
by
inserting
cryoprobe
into
the
lesion.
We
aimed
study
diagnostic
yield
and
safety
of
EBUS-TMC.
Methods:
performed
systematic
search
PubMed
Embase
databases
extract
relevant
studies.
then
meta-analysis
calculate
EBUS-TMC
compare
it
with
EBUS-TBNA.
Results:
Following
search,
we
identified
14
studies
(869
patients
undergoing
EBUS-TBNA).
EBUS-TBNA
from
wherein
both
procedures
were
performed.
The
pooled
was
92%
(95%
confidence
interval
[CI],
89%–95%).
81%
CI,
77%–85%).
risk
difference
in
11%
6%–15%,
I
2
=
0%)
when
compared.
only
complication
reported
commonly
minor
bleeding.
rate
comparable
Conclusion:
provides
greater
similar
adverse
events
compared
Future
are
required
clearly
establish
which
most
likely
benefit
this
modality.
Respirology,
Journal Year:
2024,
Volume and Issue:
29(5), P. 396 - 404
Published: Jan. 21, 2024
Endobronchial
ultrasound-guided
transbronchial
needle
aspiration
(EBUS-TBNA)
is
a
diagnostic
procedure
with
adequate
performance;
however,
its
ability
to
provide
specimens
of
sufficient
quality
and
quantity
for
treatment
decision-making
in
advanced-stage
lung
cancer
may
be
limited,
primarily
due
blood
contamination.
The
use
0.96-mm
miniforceps
biopsy
(MFB)
permits
true
histological
sampling,
but
the
resulting
small
are
unsuitable
intended
applications.
Therefore,
we
introduced
1.9-mm
standard-sized
forceps
(SFB)
compared
utility
that
MFB.
Diagnostics,
Journal Year:
2024,
Volume and Issue:
14(9), P. 965 - 965
Published: May 6, 2024
Benign
and
malignant
mediastinal
lesions
are
not
infrequently
encountered
in
clinical
practice.
Mediastinoscopy
has
long
been
considered
the
gold
standard
evaluating
pathology.
Since
its
introduction
into
practice,
endobronchial-ultrasonography-guided
transbronchial
fine
needle
aspiration
(EBUS-TBNA)
replaced
mediastinoscopy
as
initial
procedure
of
choice
to
evaluate
stage
lung
cancer.
Its
diagnostic
yield
benign
less
common
malignancies,
however,
remained
limited.
This
led
different
proceduralists
investigate
additional
procedures
improve
EBUS-TBNA.
In
recent
years,
published
reports
concluded
that
addition
EBUS-guided
intranodal
forceps
biopsy
(IFB)
cryobiopsy
(TBCB)
EBUS-TBNA
increases
especially
uncommon
malignancies.
The
purpose
this
review
is
describe
how
EBUS-IFB
EBUS-TBCB
performed,
compare
their
yields,
discuss
limitations
potential
complications.
addition,
will
conclude
with
a
proposed
algorithm
on
incorporate